Technical Support: menoci@medizin.uni-goettingen.de
Department of Medical Informatics
University Medical Center Göttingen
Imprint
View primary antibody
Basic data
| PID | primary-0794 |
| EPIC PID | https://hdl.handle.net/21.11124/primary-0794 |
| Research group | RG Zimmermann |
| Quality (mean) | no score (0.00) |
| Sharing level | Public |
Antibody data
| Antigen symbol | TUBB3 |
| Antibody Registry ID(s) | AB_2313773 |
| Name | Purified anti-Tubulin β 3 (TUBB3) Antibody |
| Alternative name | CFEOM3A |
| Lab ID | |
| Tag / Fluorophore | |
| Raised in | Mouse |
| Reacts with | human, mouse, rat |
| Clone | TUJ1 |
| Isotype | IgG2a, κ |
| Clonality | monoclonal |
| Demasking | unknown |
| Antigen | This antibody was raised against microtubules derived from rat brain. |
| Crafted By | company |
| Company / Manufacturer | Covance |
| Catalog no. | MMS-435P |
| Lot no. | |
| Description | Each lot of this antibody is quality control tested by formalin-fixed paraffin-embedded immunohistochemical staining. For immunohistochemistry, a concentration range of 1.0 - 5.0 µg/ml is suggested. For Western blotting, the suggested use of this reagent is 1.0 - 5.0 µg/ml. For immunocytochemistry, a concentration range of 1.0 - 5.0 μg/ml is recommended. It is recommended that the reagent be titrated for optimal performance for each application. |
| Localization | |
| Storage instruction | The antibody solution should be stored undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check your vial or your CoA to find the most accurate storage condition for this antibody. |
| Receipt date | 2021-10-11 00:00:00 |
| Preparation date | 2021-10-11 00:00:00 |
| Created by | Klauenberg, Vanessa |
| Last modified | Klauenberg, Vanessa |
External links
Applications
No application comments yet.
Linked publications
Establishment of two homozygous CRISPR interference (CRISPRi) knock-in human induced pluripotent stem cell (hiPSC) lines for titratable endogenous gene repression
Schoger E, Zimmermann W, Cyganek L, Zelarayán LC
Stem Cell Res 2021 : 10.1016/j.scr.2021.102473
Establishment of a second generation homozygous CRISPRa human induced pluripotent stem cell (hiPSC) line for enhanced levels of endogenous gene activation
Schoger E, Zimmermann W, Cyganek L, Zelarayán LC
Stem Cell Res 2021 : 10.1016/j.scr.2021.102518
Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation
Maurer W, Rebs S, Köhne S, Eberl H, Wollnik B, Zibat A, Streckfuss-Bömeke K
Stem Cell Res 2024 : 10.1016/j.scr.2024.103409
